Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 18,156
- Companies
- 1,062
- Drugs tracked
- 3,187
Quick answer
NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Lytgobi 4 mg film-coated tablets, 5-FU medac 50 mg/ml, Injektionslösung, Oxaliplatin Kabi 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Tevimbra 100 mg concentrate for solution for infusion, Leucovorin 10 mg/ml Lösung zur Injektion/ Infusion
Institut für biomedizinische Analytik NMR-Imaging GmbH
Colorectal cancer
1 trial -
Olumiant 2 mg film-coated tablets, Maltodextrine powder
Meda AB
Human immunodeficency virus
1 trial -
Ontruzant 420 mg powder for concentrate for solution for infusion, Oxaliplatin onkovis 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung, KEYTRUDA 25 mg/mL concentrate for solution for infusion, TAXOTERE 20 mg/1 ml concentrate for solution for infusion, Oncofolic 50 mg/ml, Injektions-/Infusionslösung, 5-FU medac 50 mg/ml, Injektionslösung
Institut für biomedizinische Analytik NMR-Imaging GmbH
HER2-positive, localized esophagogastric adenocarcinoma
1 trial -
Oxaliplatin Kabi 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Leucovorin 10 mg/ml Lösung zur Injektion/ Infusion, 5-FU medac 50 mg/ml, Injektionslösung, DS-8201a
Institut für biomedizinische Analytik NMR-Imaging GmbH
HER2 positive resectable esophagogastric adenocarcinoma
1 trial -
PALONOSETRON, FAMOTIDINE, DEXAMETHASONE PHOSPHATE, Plitidepsin, DEXCHLORPHENIRAMINE, PLACEBO
Meda AB
post-COVID-19 Condition (PCC)
1 trial -
Paclitaxel Kabi 6 mg/ml koncentrátum oldatos infúzióhoz, KEYTRUDA 25 mg/mL concentrate for solution for infusion, CARBOPLATINE MEDAC 10 mg/mL, solution à diluer pour perfusion, 68Ga-FAPI-46, DOXORUBICINE ARROW 2 mg/ml, solution pour perfusion, Epirubicin Eugia 2 mg/ml oplossing voor injectie, Cyclophosphamid beta 500 mg/ml Konzentrat zur Herstellung einer Injektions-/Infusionslösung
Institut für biomedizinische Analytik NMR-Imaging GmbH
Breast cancer
1 trial -
Pacritinib
Meda AB
Patients with myelofibrosis and platelets counts between 50 - 120 x 10e9/L
1 trial -
Veklury 100 mg powder for concentrate for solution for infusion
Meda AB
COVID-10 infection
1 trial -
Cardiac safety of treosulfan chemotherapy prior to stem cell transplantation in patients with leukemia.
Medac Gesellschaft fuer klinische Spezialpraeparate mbH
Subjects with AML ( Acute myeloid leukaemia) or MDS (Myelodysplastic syndrome) undergoing allogeneic hematopoietic stem cell transplantation
1 trial -
BENZATHINE BENZYLPENICILLIN , LINEZOLID
Meda AB
Syphilis
1 trial -
Biktarvy 50 mg/200 mg/25 mg film-coated tablets, Descovy 200 mg/25 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Pifeltro 100 mg film-coated tablets
Meda AB
Human Immunodeficiency Virus
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources